Gasdermin Family: a Promising Therapeutic Target for Stroke
- PMID: 30280366
- DOI: 10.1007/s12975-018-0666-3
Gasdermin Family: a Promising Therapeutic Target for Stroke
Abstract
Stroke is one of the leading causes of death worldwide and therapies are limited. According to the mechanisms underlying stroke, direct cell demise, destruction of organelles, blood-brain barrier disruption, neuroinflammation are potential therapeutic targets. Gasdermin (GSDM) family is a series of recently discovered proteins, which acts as the executor of pyroptosis and protagonist of membrane pore formation. It can be cleaved by inflammatory caspases that are activated by multi-protein complexes, named as inflammasomes, and divided into two domains. The N-terminal domain interacts with lipid localized in the plasma membrane as well as organelle membrane and perforates them VSports手机版. After the formation of pores, the dysfunctional structures suffer lytic death and their contents are released. In this review, we discuss the biological characteristic of GSDM family and their possible roles in stroke-induced brain injury, and based on the review, we hypothesize the feasibility of using GSDMs as a potential target for stroke treatment. .
Keywords: Gasdermin family; Mechanism; Pyroptosis; Stroke; Therapeutic target V体育安卓版. .
References
-
- Transl Stroke Res. 2017 Apr;8(2):144-156 - PubMed
-
- Ann Neurol. 2014 Feb;75(2):209-19 - PubMed
-
- Eur J Immunol. 2015 Oct;45(10):2927-36 - PubMed
-
- Transl Stroke Res. 2016 Dec;7(6):497-511 - VSports - PubMed
-
- Stroke. 2016 Aug;47(8):2160-7 - PubMed
Publication types
- Actions (VSports app下载)
MeSH terms (VSports在线直播)
- Actions (V体育平台登录)
- "V体育2025版" Actions
- "VSports" Actions
Substances
- VSports注册入口 - Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical